Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell therapies: GlobalData Read more
Blockchain For Impact announces USD 15 million fund for biomedical research and innovation in India Read more
Large pharma cos to invest nearly 7 per cent revenue on next-gen labs by 2025: Capgemini report Read more
Suven announces randomisation of first patient in Phase-2 POC clinical trial of Ropanicant (SUVN-911) Read more
PDC*line Pharma, partners get €8.1mn from Walloon region, BioWin for personalised therapeutic vaccine Read more
AstraZeneca shares data from HIMALAYA, MATTERHORN Phase III studies at ESMO Asia Congress 2023 Read more
Industry and academia should work together to combine discovery biology and translational research Read more